Editorial · 8 May 2017
Conference abstractPublished 20 Oct 2016
Perspectives and new process developments in cell therapy
University of Leipzig, Germany
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
About 20 years were needed to implement the invention of monoclonal antibodies with clinical and industrial acceptance for novel therapies, and another 10 years for reaching blockbuster level. Now the time has come to welcome cell therapies at the clinical stage with complex procedures that have been developed throughout the last 10 to 15 years. Dendritic cell vaccines, NK cells and chimeric antigen receptor (CAR) T cells are being explored in various configurations in clinical studies. Connected with these developments are new challenges. Certain regulatory authorities find it difficult to handle processes with mixed categories like cell therapy and gene therapy, or combinations of drugs with medical devices. On the manufacturing site originates a demand of for reduction product costs by drastically reducing manual processing steps and implementing automation. Moreover, a better understanding of mechanisms at the molecular and cellular level may reduce costs and risks of new therapeutic procedures for patients. It is well established that anti-CD4 antibody treatment of helper T cells would induce immunological tolerance when applied in the ongoing phase of an immune response. We studied the mechanism and could further develop the procedure to an applicable technology that allows extracorporeal treatment of T cell containing allotransplants thus reducing treatment risks and product costs significantly. If applied in the field of organ transplantation and transplantation antigens the procedure may be useful for preventing graft rejection of organ transplants or the graft versus host disease (GvHD), the most severe adverse reaction upon allogeneic stem cell transplantation.
Subjects
Biochemistry & BiotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 26 Jun 2013
Malaria and matrix metalloproteinases: New perspectives for adjuvant therapy
Research article · 2014
Construction of the athletes exchange system in the perspective of development of Chinese sports in new era
Article · 24 Jun 2026
Mapping Cellular State Dynamics Through Single-Cell Analysis: New Perspectives on Cellular Adaptation and Identity
Commentary · 2016
Back on Track: New Perspectives on Cancer Cell Reprogramming
More from this journal
The newest in Journal of Bioprocessing & Biotechniques.
Commentary · 29 Nov 2025
Bioseparation Evolution: Enhanced Efficiency and Selectivity
Commentary · 29 Nov 2025
Advancing Bioprocess Scale-Down: Technologies for Optimization
Brief report · 29 Nov 2025
Bioprocessing Sustainable Packaging Biomaterials: A Review
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioprocessing & Biotechniques
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Frank Emmrich”

